TELO GENOMICS CORP (TELO.CA) Stock Income Statement
Canada - TSX-V:TELO - CA87975M2085 - Common Stock
0.07 CAD
0 (-6.67%)
| TTM (2025-3-31) | 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 2.63M | 2.72M | 2.82M | 2.11M | 1.26M | |||
| Research and Development | 1.41M | 1.32M | 1.33M | 1.12M | 603.90K | |||
| Selling, General, and Administrative Expenses | 1.20M | 1.36M | 1.46M | 986.60K | 653.30K | |||
| Operating Income | -2.63M | -2.72M | -2.82M | -2.11M | -1.26M | |||
| Interest Income/Expense | N/A | N/A | N/A | N/A | 0.00 | |||
| Non Recurring Items | N/A | 10.00K | N/A | 0.00 | 187.20K | |||
| Income Before Taxes | -2.61M | -2.71M | -2.82M | -2.11M | -1.07M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -2.61M | -2.71M | -2.82M | -2.11M | -1.07M | |||
| EBITDA | -2.61M | -2.68M | -2.79M | -2.05M | -1.20M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.03 | -0.04 | -0.05 | -0.04 | -0.02 | |||
| Statistics | ||||||||
All data in CAD